Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial
Complementary Medicine Research · 2024
DOI: 10.1159/000536395 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Complementary Medicine Research, 2024. Verfasst von Abhijit Dutta und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Cooperation Section, Ministry of Ayush (Government of India), New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Homeopathy, Materia Medica, COVID-19 Drug Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Introduction
Homeopathic medicines have been used for decades in the prevention and treatment of infectious diseases. However, the preventive efficacy of specific homeopathic medicines in COVID-19 is not well characterized. This study aimed to evaluate the comparative efficacy of prespecified homeopathic medicines in preventing COVID-19.
Methods
A community-based, double-blind, randomized, placebo-controlled trial was conducted on 4,034 participants residing in Ward No. 27 of the Howrah Municipal Corporation in India. Participants were randomized to receive one of three prespecified homeopathic medicines [Influenzinum 30C, Arsenicum album 30C, Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum®)], or placebo. The outcomes were the incidence of laboratory-confirmed and suspected cases of COVID-19 during a follow-up period of 1 month.
Results
During the follow-up period, a total of 13 new laboratory-confirmed COVID-19 cases were reported in the study population. Among these, 5 cases in Influenzinum group, 2 cases in Arsenicum album group, 1 case in Oscillococcinum® group, and 5 cases in Placebo group were reported. On the other hand, number of suspected COVID-19 cases was significantly less in all the three homeopathic medicine groups compared to placebo. The least number of suspected cases reported in the Oscillococcinum® group (aOR: 0.058; 95% confidence interval [CI]: 0.029, 0.114), followed by the Arsenicum album (aOR: 0.337; 95% CI: 0.238, 0.475) and Influenzinum (aOR: 0.539; 95% CI: 0.401, 0.726) groups.
Conclusion
Prespecified homeopathic medicines, particularly Oscillococcinum® and Arsenicum album 30C, may have a role in preventing COVID-19, especially in reducing the incidence of suspected or COVID-19-like respiratory illnesses. However, the result failed to demonstrate a statistically significant difference in the occurrence of confirmed cases of COVID-19 between the study groups. Further research is needed to evaluate the efficacy of these medicines in different populations and settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Cooperation Section, Ministry of Ayush (Government of India), New Delhi, India.
- State Homoeopathic Dispensary, District Hospital, Darjeeling, India.
- Department of Pathology and Microbiology, D. N. De Homoeopathic Medical College and Hospital, Kolkata, India.
- Department of Community Medicine, Calcutta National Medical College and Hospital, Kolkata, India.
- Department of Materia Medica, Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Howrah, India.
- Department of Pathology and Microbiology, Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, Howrah, India.
Zitieren
APA
Dutta, A., Manna, A., Ghosh, S., Mundle, M., Saha, M., Gourav, K., Maiti, S., & Chattopadhyay, B. (2024). Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. Complementary Medicine Research. https://doi.org/10.1159/000536395
Vancouver
Dutta A, Manna A, Ghosh S, Mundle M, Saha M, Gourav K, et al. Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial. Complementary Medicine Research. 2024. doi:10.1159/000536395
BibTeX
@article{Dutta2024,
author = {Dutta, Abhijit and Manna, Arijit and Ghosh, Shubhamoy and Mundle, Malay and Saha, Madhabananda and Gourav, Kumar and Maiti, Sukhdeb and Chattopadhyay, Bhargab},
title = {Prespecified Homeopathic Medicines in the Prevention of Confirmed and Suspected Cases of COVID-19: A Community-Based, Double-Blind, Randomized, Placebo-Controlled Prophylaxis Trial},
journal = {Complementary Medicine Research},
year = {2024},
doi = {10.1159/000536395}
}
EUVIMED